About EarlySight
EarlySight is a company based in Lausanne (Switzerland) founded in 2016 by Francine Behar-Cohen, Mathieu Kunzi, and Timothe Laforest. EarlySight has raised $6.56 million across 5 funding rounds from investors including Zurcher Kantonalbank, EIT Health and CADFEM. EarlySight offers products and services including Cellularis Discovery. EarlySight operates in a competitive market with competitors including Optomed, Eyenuk, LKC Technologies, Heidelberg Engineering and Wooptix, among others.
- Headquarter Lausanne, Switzerland
- Founders Francine Behar-Cohen, Mathieu Kunzi, Timothe Laforest
- SectorsHealthcare
- Email••••••••
- Website earlysight.com
- Social LinkedIn
- Legal Name Earlysight Sa
- Total Equity Funding$6.56M (USD)
in 5 rounds
- Latest Funding Round$3.88M (USD), Seed
Sep 2025
- InvestorsZurcher Kantonalbank
& 7 more
Products & Services of EarlySight
EarlySight offers a comprehensive portfolio of products and services, including Cellularis Discovery.
Provides cellular-level images of retina for disease detection and monitoring.
Funding Insights of EarlySight
EarlySight has successfully raised a total of $6.56M across 5 strategic funding rounds. The most recent funding activity was a Seed round of $3.88 million completed in September 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $6.56M
- Total Rounds 5
- Last Round Seed — $3.88M
- Investors Count 8
All 5 funding rounds of EarlySight with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2025 | $3.88M | Seed | – | Verve Ventures, Nina Capital | |
| Oct 2023 | $111,279 | Seed | – | Fongit | – |
| May 2021 | $2.57M | Seed | – | Verve Ventures | |
| Feb 2020 | $102,917 | Debt – Conventional | – | – | |
| Jul 2019 | – | Grant | – | – |
8 investors in total: 8 institutional.
Investors in EarlySight
EarlySight has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Zurcher Kantonalbank, EIT Health and CADFEM.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage startups are accelerated and supported by Fongit in Switzerland. | – | fongit.ch | Geneva, Switzerland | |
Venture capital firm focused on science and tech-driven startups | – | verve.vc | Berlin, Germany | |
- | – | nina.capital | - | |
Grants and loans are provided by FIT for innovative startups. | 1994 | fondation-fit.ch | Lausanne, Switzerland | |
Healthcare startups are accelerated and incubated through specialized programs. | 2015 | eithealth.eu | Munich, Germany | |
Nova Capital is engaged in complex portfolio acquisitions and investments. | – | nova-cap.com | London, United Kingdom | |
CAE simulation solutions are provided for engineering applications worldwide. | 1985 | cadfem.net | Munich, Germany | |
Commercial banking services are provided across Switzerland by Zurcher Kantonalbank. | 1870 | zkb.ch | Zurich, Switzerland |
Investor details for EarlySight
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of EarlySight
9 people are tracked at EarlySight (6 in leadership, 1 in board & advisors, 2 in team).
| Name | Role | Group |
|---|---|---|
Francine Behar-Cohen | Co-Founder | Leadership |
Mathieu Kunzi | Co-Founder & CTO | Leadership |
Timothe Laforest | Co-Founder & CEO | Leadership |
Sonja Simon - Zoula | Head of Clinical Operation | Leadership |
Benedetto Sgroi | Global Head of Business Dev, Sales and Marketing | Leadership |
Timothé Laforest | CEO & Co-founder | Leadership |
Christophe Moser | Advisor & Co-founder | Board & advisors |
Jan Krizek, PhD | Lead R&D Engineer | Team |
Thomas Ibanez | Software Engineer | Team |
Complete people profiles for EarlySight
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of EarlySight
3 dated milestones of EarlySight across 9 years, from founding to its latest funding, stage changes and deals.
- Founded EarlySight is founded.
- Funding First funding round.
- Funding Latest funding round, Seed, of $3.9M.
Competitors of EarlySight
EarlySight operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Optomed, Eyenuk, LKC Technologies, Heidelberg Engineering and Wooptix, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| optomed.com | 2004 | Alpharetta, United States | $4.92M | 114 | Provider of handheld fundus cameras and software solutions for eye screening | |
| eyenuk.com | 2010 | Los Angeles, United States | $38.05M | – | AI-driven retinal image analysis for diabetic retinopathy detection is developed. | |
| lkc.com | 1976 | Gaithersburg, United States | $3.89M | 35 | Non-mydriatic hand-held devices for visual electrophysiology testing are developed. | |
| heidelbergengineering.com | 1990 | Heidelberg, Germany | – | – | Diagnostic imaging devices are developed for early eye disease detection. | |
| wooptix.com | 2016 | Madrid, Spain | $24.92M | – | Application that allows 3D capture using single standard camera | |
| aeyehealth.com | 2018 | New York, United States | – | – | AI-based retinal imaging software is provided for eye diagnosis. | |
| oxxius.com | 2002 | Lannion, France | $14.26M | – | Diversified laser systems are developed for biophotonics and spectroscopy applications. | |
| retinalgenix.com | 2014 | United States | $698,089 | – | Medical devices for diabetic retinopathy diagnosis are manufactured. | |
| freedom-meditech.com | 2006 | San Diego, United States | $12.89M | – | Ocular diagnostic for chronic diseases |
Detailed competitors of EarlySight
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Earlysight
Complete news archive for EarlySight
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to EarlySight
10 companies that operate in the same segment as EarlySight (Ophthalmology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of a wide range of eye care products | 1945 | Fort Worth, Texas, United States | USD 171.61 M | USD 9.64 B | 25,600 | |
Genetic medicines are developed by 4DMT for transformative therapies. | 2013 | Emeryville, California, United States | USD 186.59 M | USD 85.21 M | 227 | |
Developer of antibodies to treat complement-mediated neurodegenerative diseases | 2011 | San Francisco, California, United States | USD 256 M | – | 100 | |
Ophthalmic pharmaceuticals for diabetic macular edema are developed and commercialized. | 2003 | Alpharetta, Georgia, United States | USD 66.8 M | USD 80.75 M | 79 | |
AI-powered portable solutions for ophthalmic screening and diagnosis are developed. | 2009 | Bengaluru, Karnataka, India | USD 25.01 M | USD 4.85 M | 135 | |
Gene therapies for ocular and neurodegenerative diseases are developed. | 2015 | New York, New York, United States | – | USD 81.39 M | 381 | |
Small molecule therapeutics for ophthalmic disorders are developed. | 1987 | Watertown, United States | – | USD 31.37 M | 165 | |
Therapies for metabolic and orphan diseases are developed by Rezolute. | 2012 | Denver, Colorado, United States | – | – | 59 | |
Manufacturer of portable digital eye imaging devices and cloud-based healthcare platforms | 2010 | Bengaluru, Karnataka, India | USD 18.12 M | USD 4.78 M | 145 | |
Therapeutics for retinal diseases are developed by the company. | 2009 | Palo Alto, California, United States | USD 35.84 M | – | 109 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about EarlySight
EarlySight was founded in 2016 and raised its 1st funding round 3 years after it was founded.
EarlySight is headquartered in Lausanne, Switzerland. It is registered at Lausanne, Vaud, Switzerland.
Timothe Laforest is the current CEO of EarlySight. They have also founded this company.
EarlySight is a funded company, having raised a total of $6.56M across 5 funding rounds to date.
EarlySight was founded in 2016 and is based in Lausanne, Switzerland. Retinal imaging technologies are developed for ophthalmologists to visualize disease origins, including age-related macular degeneration. Measurements of retinal cell density and size are enabled. Micro-vasculature structures and small capillaries in retinal disorders are observed through these solutions in the health technology sector.
EarlySight's top competitors include Heidelberg Engineering, Eyenuk and Optomed.
EarlySight offers Cellularis Discovery.
EarlySight has 8 investors. Key investors include Zurcher Kantonalbank, EIT Health, CADFEM, Fongit, and Verve Ventures.
EarlySight operates through Earlysight Sa.